Latest News on Cipla
Showing of 0 - 10 from 138 results
Cipla - Total results - 138
-
Mar 18, 2019
Cipla, Wellthy ink pact to offer digital therapeutics for diabetes, cardiovascular diseases
The platform brings together behavioural science, real world clinical evidence and artificial intelligence to provide real time monitoring, coaching and advice to patients, and virtual clinical assistance to doctors. -
Jan 30, 2019
Watch Priyanka Chopra bust 3 myths about asthma
Priyanka Chopra knows a lot about the myths and so-called mysteries surrounding asthma. -
Dec 12, 2018
Asthma couldn't stop Priyanka Chopra from becoming a superstar
Check out the complete video of Priyanka Chopra busting 5 common myths around Asthma and inhalers. -
Nov 13, 2018
Cipla's subsidiary InvaGen Pharmaceuticals Inc to acquire US-based Avenue Therapeutics for $215 mn
Avenue Therapeutics is focused on the development and commercialisation of intravenous (IV) Tramadol, a painkiller. -
Nov 05, 2018
Cipla shares tank over 7% after pharma firm reports 15.64% fall in Q2 consolidated net profit
Intra-day, Cipla shares tanked 8.28 percent to Rs 558.10 -
Aug 09, 2018
Cipla shares jump 5% to Rs 661.90 after company posted 10% rise in Q1 net profit
Cipla's total income from operations stood at Rs 3,939 crore in the quarter, as compared to Rs 3,525 crore earlier -
Aug 06, 2018
Q1 results, global cues, crude prices, monsoon session of Parliament to affect affect markets' moves this week
Market analysts opined that crude oil prices and developments in the monsoon session of parliament will also affect the markets' movement. -
Apr 04, 2018
True tech power comes from harvesting patents: ISRO, Cipla and Biocon show the way for future entrepreneurs
Is there an entrepreneur out there who has the money and the audacity to gamble on a new future? India could do with some audacious private entrepreneurs. -
Mar 20, 2018
Nifty snaps 4-day fall, up 30 points to 10,124 mark ahead of US Fed meet; IT stocks rise 1.51%
The market breadth, indicating its overall health, remained negative as a total of 691 scrips advanced and 1,124 declined. -
Dec 08, 2017
Sensex recaptures 33,000 peak, up 190 points; Tata Motors, Bharti Airtel, Adani Ports biggest gainers
At Sensex, retail investors and domestic institutions gathered momentum amid strong global cues causing a rally in key index
